The diagnosis of CF, including cases caused by the Delta F508 mutation, typically involves a combination of genetic testing and clinical evaluations. Newborn screening programs often include tests for CFTR mutations. A positive screening result is usually followed by a sweat test to measure the concentration of chloride in the sweat, which is abnormally high in individuals with CF.
